sampleID;cohort;histological_type;IntegrativeCluster;msi_status_7_marker_call;mRNA_cluster;PANCAN_DNAMethyl_1;PANCAN_DNAMethyl_2;pathologic_T;pathologic_N;pathologic_M;pathologic_stage;grade;clinical_T;clinical_N;clinical_M;clinical_stage; age ;gender;OS_IND;vital_status;OS_months;days_to_death;Days.to.Last.Followup;RFS_months;Disease.Free.Status;TIME_TO_EVENT;days_to_new_tumor;new_tumor;new_tumor_event_type;person_cancer_status;number_pack_years_smoked;tobacco_smoking_history
TCGA-4E-A92E;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage I;54;FEMALE;0;Alive;0.43;NA;0;0.43;DiseaseFree;;;[Unknown];;TUMOR FREE;;
TCGA-5B-A90C;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;69;FEMALE;0;Alive;39.49;NA;883;16.98;Recurred/Progressed;;;YES;;TUMOR FREE;;
TCGA-5S-A9Q8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;51;FEMALE;0;Alive;10.28;NA;33;10.28;DiseaseFree;;;NO;;[Unknown];;
TCGA-A5-A0G2;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSI-L;1;;;;;;;Grade 3;;;;Stage IIIB;57;FEMALE;0;Alive;149.44;NA;4054;149.44;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-A5-A0G3;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;61;FEMALE;0;Alive;46.91;NA;1079;26.12;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-A5-A0G5;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSI-L;1;;;;;;;Grade 3;;;;Stage IB;73;FEMALE;0;Alive;36.99;NA;790;36.99;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0G9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IB;79;FEMALE;0;Alive;83.44;NA;2165;83.44;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GB;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 3;;;;Stage IB;65;FEMALE;0;Alive;32.75;NA;275;32.75;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GE;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IA;38;FEMALE;0;Alive;105.29;NA;2717;105.29;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GG;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 1;;;;Stage IA;76;FEMALE;0;Alive;123.59;NA;2517;123.59;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;57;FEMALE;0;Alive;74.05;NA;1672;74.05;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 2;;;;Stage IA;63;FEMALE;0;Alive;88.11;NA;1750;88.11;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 2;;;;Stage IA;44;FEMALE;0;Alive;65.7;NA;1447;0.39;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-A5-A0GM;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;53;FEMALE;0;Alive;60.48;NA;1448;60.48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GN;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 1;;;;Stage IB;65;FEMALE;0;Alive;60.48;NA;1477;60.48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GP;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;1;;;;;;;Grade 1;;;;Stage IA;58;FEMALE;0;Alive;46.52;NA;1087;46.52;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IB;76;FEMALE;0;Alive;73.82;NA;1167;73.82;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 2;;;;Stage IA;69;FEMALE;0;Alive;36.79;NA;780;36.79;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;58;FEMALE;0;Alive;28.25;NA;496;28.25;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;67;FEMALE;0;Alive;53.98;NA;486;9.99;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-A5-A0GW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;46;FEMALE;0;Alive;23.19;NA;385;23.19;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0GX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IA;53;FEMALE;0;Alive;68.59;NA;925;68.59;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0R6;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC1;64;FEMALE;0;Alive;37.88;NA;369;31.57;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-A5-A0R7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 2;;;;Stage IA;55;FEMALE;0;Alive;17.58;NA;40;17.58;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0R8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IB;81;FEMALE;0;Alive;19.58;NA;126;1.38;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-A5-A0R9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IA;51;FEMALE;0;Alive;24.61;NA;294;24.61;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0RA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;68;FEMALE;0;Alive;29.04;NA;556;29.04;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0VP;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 3;;;;Stage IA;74;FEMALE;0;Alive;42.31;NA;928;42.31;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A0VQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IA;62;FEMALE;0;Alive;15.93;NA;177;15.93;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A1OF;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;47;FEMALE;0;Alive;31.96;NA;241;31.96;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A1OH;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;86;FEMALE;0;Alive;36.3;NA;539;36.3;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-A5-A1OJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage IA;31;FEMALE;0;Alive;33.05;NA;292;33.05;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A1OK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage IIIA;63;FEMALE;0;Alive;30.12;NA;244;30.12;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A2K2;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;77;FEMALE;0;Alive;118.1;NA;2769;118.1;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A2K3;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;68;FEMALE;0;Alive;66.1;NA;1409;66.1;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A2K5;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;76;FEMALE;0;Alive;24.7;NA;162;24.7;DiseaseFree;;;NA;;NA;;
TCGA-A5-A2K7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;41;FEMALE;0;Alive;34.92;NA;157;34.92;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A3LO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;64;FEMALE;0;Alive;25.49;NA;223;25.49;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A3LP;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;74;FEMALE;0;Alive;14.95;NA;230;14.95;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-A5-A7WJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;64;FEMALE;0;Alive;11.2;NA;341;11.2;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-A5-A7WK;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage IA;71;FEMALE;0;Alive;18.4;NA;248;11.5;Recurred/Progressed;;;NO;;TUMOR FREE;;
TCGA-A5-AB3J;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;52;FEMALE;0;Alive;16.82;NA;251;16.82;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A2QK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;65;FEMALE;0;Alive;21.12;NA;12;19.91;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AJ-A2QL;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC1;60;FEMALE;0;Alive;19.78;NA;49;19.78;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AJ-A2QM;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;67;FEMALE;0;Alive;29.37;NA;26;29.37;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A2QN;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;60;FEMALE;0;Alive;35.12;NA;73;35.12;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3BD;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC2;57;FEMALE;0;Alive;34.13;NA;15;34.13;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3BF;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC2;65;FEMALE;0;Alive;18.1;NA;34;16.72;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AJ-A3BG;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage IA;65;FEMALE;0;Alive;18.07;NA;23;15.77;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AJ-A3BH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;NA;FEMALE;0;Alive;NA;NA;NA;NA;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3BI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;67;FEMALE;0;Alive;18.89;NA;68;12.25;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AJ-A3BK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IC;68;FEMALE;0;Alive;33.87;NA;51;33.87;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3EK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;53;FEMALE;0;Alive;14.65;NA;64;14.65;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3EL;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;47;FEMALE;0;Alive;22.47;NA;65;22.47;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3EM;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;69;FEMALE;0;Alive;22.24;NA;50;22.24;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3IA;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;77;FEMALE;0;Alive;20.8;NA;28;20.8;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3NC;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;63;FEMALE;0;Alive;36.96;NA;210;36.96;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3NE;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;46;FEMALE;0;Alive;20.63;NA;78;20.63;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3NF;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;60;FEMALE;0;Alive;21.19;NA;41;21.19;DiseaseFree;;;NA;;NA;;
TCGA-AJ-A3NG;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage II;83;FEMALE;0;Alive;15.6;NA;52;15.6;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3OJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;54;FEMALE;0;Alive;15.34;NA;59;15.34;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3OK;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;73;FEMALE;0;Alive;15.93;NA;142;15.93;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AJ-A3QS;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;57;FEMALE;0;Alive;16.85;NA;56;16.85;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A3TW;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;78;FEMALE;0;Alive;16.85;NA;52;16.85;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A4ZG;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;53;FEMALE;0;Alive;16.36;NA;28;16.36;DiseaseFree;;;NO;;WITH TUMOR;;
TCGA-AJ-A5DV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;65;FEMALE;0;Alive;22.31;NA;148;22.31;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A5DW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;56;FEMALE;0;Alive;12.81;NA;71;12.81;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A6NU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;64;FEMALE;0;Alive;20.76;NA;30;20.76;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A8CT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;58;FEMALE;0;Alive;2.69;NA;82;2.69;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A8CV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;58;FEMALE;0;Alive;35.09;NA;71;35.09;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AJ-A8CW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;64;FEMALE;0;Alive;0.13;NA;4;0.13;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-AP-A051;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSI-H;2;;;;;;;Grade 3;;;;Stage IA;69;FEMALE;0;Alive;129.7;NA;2545;129.7;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A056;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSI-L;1;;;;;;;Grade 3;;;;Stage II;64;FEMALE;0;Alive;86.01;NA;2026;86.01;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A059;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;69;FEMALE;0;Alive;48;NA;1461;48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A05D;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;67;FEMALE;0;Alive;57.75;NA;1364;57.75;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A05H;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;75;FEMALE;0;Alive;45.5;NA;831;45.5;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A05J;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage II;66;FEMALE;0;Alive;36.86;NA;639;36.86;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A05O;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IB;68;FEMALE;0;Alive;12.61;NA;384;11.17;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AP-A05P;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;54;FEMALE;0;Alive;20.89;NA;260;20.89;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0L9;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IA;71;FEMALE;0;Alive;125.33;NA;3444;125.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IB;63;FEMALE;0;Alive;117.9;NA;2907;117.9;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LE;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IA;57;FEMALE;0;Alive;110.28;NA;2986;110.28;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LF;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IVB;82;FEMALE;0;Alive;93.92;NA;2859;93.92;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AP-A0LG;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 3;;;;Stage IA;54;FEMALE;0;Alive;66.2;NA;2015;66.2;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LI;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;67;FEMALE;0;Alive;97.63;NA;2602;97.63;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;42;FEMALE;0;Alive;46.68;NA;1421;46.68;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LL;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;56;FEMALE;0;Alive;83.9;NA;2141;25.95;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A0LM;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;3;;;;;;;Grade 3;;;;Stage IIIC2;33;FEMALE;0;Alive;27.1;NA;825;27.1;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LN;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;56;FEMALE;0;Alive;82.46;NA;1993;82.46;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LP;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IA;76;FEMALE;0;Alive;61.6;NA;1875;61.6;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage IA;59;FEMALE;0;Alive;80.72;NA;1906;80.72;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 2;;;;Stage IA;63;FEMALE;0;Alive;95.4;NA;1668;95.4;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage II;57;FEMALE;0;Alive;49.18;NA;1185;49.18;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A0LV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;39;FEMALE;0;Alive;25.07;NA;385;25.07;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1DH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;62;FEMALE;0;Alive;71.62;NA;1816;71.62;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1DK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;53;FEMALE;0;Alive;90.9;NA;1650;90.9;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1DM;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 1;;;;Stage IA;60;FEMALE;0;Alive;55.85;NA;1329;55.85;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1DO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 2;;;;Stage IA;62;FEMALE;0;Alive;31.27;NA;952;31.27;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1DR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 2;;;;Stage IIIC1;59;FEMALE;0;Alive;49.11;NA;1131;49.11;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1DV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage II;59;FEMALE;0;Alive;6.7;NA;204;6.7;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1E0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 2;;;;Stage IIIC2;40;FEMALE;0;Alive;60.18;NA;691;60.18;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1E1;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 2;;;;Stage IA;74;FEMALE;0;Alive;45.83;NA;317;45.83;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AP-A1E3;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC1;45;FEMALE;0;Alive;27.83;NA;523;27.83;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AP-A1E4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 2;;;;Stage IB;54;FEMALE;0;Alive;51.08;NA;267;5.19;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AW-A1PO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIA;66;FEMALE;0;Alive;0.56;NA;17;0.56;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A05T;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IB;82;FEMALE;0;Alive;33.18;NA;603;33.18;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A05U;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IB;56;FEMALE;0;Alive;29.66;NA;903;29.66;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A05W;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 1;;;;Stage IIB;60;FEMALE;0;Alive;80.49;NA;2079;80.49;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A05Y;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IB;57;FEMALE;0;Alive;88.17;NA;2191;6.37;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AX-A05Z;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;3;;;;;;;Grade 2;;;;Stage IIIA;37;FEMALE;0;Alive;71.45;NA;1413;71.45;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A060;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 3;;;;Stage IC;77;FEMALE;0;Alive;35.32;NA;1075;35.32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A062;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IB;53;FEMALE;0;Alive;45.96;NA;1399;45.96;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A063;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IB;63;FEMALE;0;Alive;79.4;NA;2025;79.4;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A064;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IIA;81;FEMALE;0;Alive;49.84;NA;1064;49.84;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A06B;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIA;72;FEMALE;0;Alive;67.61;NA;1640;67.61;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A06F;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-L;1;;;;;;;Grade 3;;;;Stage IVA;59;FEMALE;0;Alive;57.42;NA;1554;57.42;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A06H;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 1;;;;Stage IIIA;60;FEMALE;0;Alive;27.37;NA;833;27.37;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AX-A06J;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 3;;;;Stage IB;71;FEMALE;0;Alive;29.99;NA;913;29.99;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A06L;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 1;;;;Stage IB;63;FEMALE;0;Alive;60.61;NA;1480;60.61;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AX-A0IU;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;79;FEMALE;0;Alive;35.71;NA;868;35.71;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A0IW;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSI-L;1;;;;;;;Grade 3;;;;Stage IIIA;67;FEMALE;0;Alive;37.75;NA;1149;37.75;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A0IZ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;3;;;;;;;Grade 3;;;;Stage IB;53;FEMALE;0;Alive;43.79;NA;1333;43.79;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A0J0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;1;;;;;;;Grade 2;;;;Stage IB;47;FEMALE;0;Alive;40.08;NA;1220;40.08;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A0J1;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IB;80;FEMALE;0;Alive;77.33;NA;2004;77.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A1C4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 2;;;;Stage IB;52;FEMALE;0;Alive;13.27;NA;404;13.27;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A1C5;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIC;47;FEMALE;0;Alive;32.88;NA;584;32.88;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AX-A1C7;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;77;FEMALE;0;Alive;34.63;NA;516;12.81;Recurred/Progressed;;;NA;;NA;;
TCGA-AX-A1C8;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;77;FEMALE;0;Alive;25.49;NA;412;25.49;DiseaseFree;;;NA;;NA;;
TCGA-AX-A1C9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 2;;;;Stage IB;73;FEMALE;0;Alive;26.35;NA;464;26.35;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A1CA;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;Indeterminant;1;;;;;;;Grade 3;;;;Stage IB;70;FEMALE;0;Alive;32;NA;617;32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A1CC;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSI-L;1;;;;;;;Grade 3;;;;Stage IC;65;FEMALE;0;Alive;25.89;NA;378;25.89;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A1CE;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IB;60;FEMALE;0;Alive;34.07;NA;610;34.07;DiseaseFree;;;NA;;NA;;
TCGA-AX-A1CF;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IVB;69;FEMALE;0;Alive;76.77;NA;2337;28.75;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AX-A1CI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 1;;;;Stage IB;61;FEMALE;0;Alive;85.41;NA;2207;85.41;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A1CJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;Indeterminant;3;;;;;;;Grade 2;;;;Stage IC;59;FEMALE;0;Alive;73.36;NA;1646;73.36;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A1CK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 2;;;;Stage IB;58;FEMALE;0;Alive;80.19;NA;2053;80.19;DiseaseFree;;;NA;;NA;;
TCGA-AX-A1CN;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-L;1;;;;;;;Grade 3;;;;Stage IIB;54;FEMALE;0;Alive;37.55;NA;764;36.3;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AX-A1CP;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IA;84;FEMALE;0;Alive;36.37;NA;1107;23.72;Recurred/Progressed;;;NA;;NA;;
TCGA-AX-A1CR;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIB;70;FEMALE;0;Alive;23.03;NA;337;23.03;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A2H5;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;67;FEMALE;0;Alive;71.19;NA;2167;71.19;DiseaseFree;;;NA;;NA;;
TCGA-AX-A2H8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-L;NA;;;;;;;Grade 3;;;;Stage IB;64;FEMALE;0;Alive;61.14;NA;1861;61.14;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A2HA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;35;FEMALE;0;Alive;81.31;NA;2090;81.31;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A2HC;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIC;53;FEMALE;0;Alive;34.3;NA;1016;24.84;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AX-A2HD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIA;69;FEMALE;0;Alive;46.45;NA;1232;46.45;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AX-A2HF;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;67;FEMALE;0;Alive;27.86;NA;489;27.86;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A2HG;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IC;56;FEMALE;0;Alive;38.21;NA;661;38.21;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A2HH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 3;;;;Stage IA;60;FEMALE;0;Alive;17.74;NA;540;17.74;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-AX-A2HJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IC;35;FEMALE;0;Alive;30.72;NA;831;30.72;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A2IO;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIA;83;FEMALE;0;Alive;64.88;NA;1177;64.88;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-AX-A3FS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;82;FEMALE;0;Alive;0.23;NA;7;0.23;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3FT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;64;FEMALE;0;Alive;0.2;NA;3;0.2;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3FV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;62;FEMALE;0;Alive;-0.2;NA;-13;-0.2;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3FW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;66;FEMALE;0;Alive;0.56;NA;10;0.56;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3FZ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIB;33;FEMALE;0;Alive;0.2;NA;6;0.2;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3G3;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;58;FEMALE;0;Alive;1.38;NA;1;1.38;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3G4;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;60;FEMALE;0;Alive;0.3;NA;4;0.3;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3G6;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;67;FEMALE;0;Alive;0.26;NA;0;0.26;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3G7;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;71;FEMALE;0;Alive;0.3;NA;7;0.3;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3G8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;76;FEMALE;0;Alive;1.18;NA;36;1.18;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3G9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;63;FEMALE;0;Alive;18.33;NA;254;18.33;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3GB;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;73;FEMALE;0;Alive;14.45;NA;440;14.45;DiseaseFree;;;NA;;NA;;
TCGA-AX-A3GI;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;66;FEMALE;0;Alive;0.39;NA;4;0.39;DiseaseFree;;;NA;;NA;;
TCGA-B5-A0JN;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSI-L;NA;;;;;;;Grade 3;;;;Stage IVB;84;FEMALE;0;Alive;80.32;NA;2068;80.32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0JR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 3;;;;Stage IB;73;FEMALE;0;Alive;56.87;NA;1465;56.87;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0JS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;54;FEMALE;0;Alive;86.3;NA;1241;86.3;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0JT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IIIA;63;FEMALE;0;Alive;55.26;NA;1312;55.26;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0JU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 2;;;;Stage IB;57;FEMALE;0;Alive;59.2;NA;1483;59.2;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0JV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IA;63;FEMALE;0;Alive;85.94;NA;1125;22.93;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A0JX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage IB;62;FEMALE;0;Alive;58.71;NA;1360;58.71;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0JY;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;1;;;;;;;Grade 3;;;;Stage IIIC1;50;FEMALE;0;Alive;69.22;NA;809;69.22;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0JZ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 3;;;;Stage IIIC1;60;FEMALE;0;Alive;71.39;NA;689;11.7;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A0K0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;48;FEMALE;0;Alive;48.55;NA;679;48.55;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0K1;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;69;FEMALE;0;Alive;36.47;NA;746;36.47;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0K2;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IIIA;54;FEMALE;0;Alive;72.57;NA;683;72.57;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0K4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IB;51;FEMALE;0;Alive;57.72;NA;466;57.72;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0K6;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IA;58;FEMALE;0;Alive;64.16;NA;418;64.16;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0K7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;64;FEMALE;0;Alive;63.5;NA;372;10.58;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A0K8;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;71;FEMALE;0;Alive;27.83;NA;543;27.83;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A0KB;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IB;62;FEMALE;0;Alive;27.07;NA;125;22.63;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A11E;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;1;;;;;;;Grade 3;;;;Stage IB;53;FEMALE;0;Alive;59.79;NA;265;59.79;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11F;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IA;55;FEMALE;0;Alive;185.64;NA;5280;52.89;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A11G;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IA;71;FEMALE;0;Alive;113.27;NA;3077;113.27;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11H;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IIIA;67;FEMALE;0;Alive;88.27;NA;2317;88.27;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11I;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IVB;65;FEMALE;0;Alive;75.66;NA;2038;63.73;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-B5-A11J;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IA;64;FEMALE;0;Alive;54.4;NA;1291;54.4;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11M;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 1;;;;Stage IA;43;FEMALE;0;Alive;44.74;NA;1117;44.74;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11N;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;3;;;;;;;Grade 1;;;;Stage IA;69;FEMALE;0;Alive;61.63;NA;1147;61.63;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11O;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;62;FEMALE;0;Alive;85.71;NA;1042;63.21;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A11P;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage IB;87;FEMALE;0;Alive;52;NA;1120;52;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11Q;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IIIA;64;FEMALE;0;Alive;32.06;NA;703;32.06;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11R;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 3;;;;Stage II;51;FEMALE;0;Alive;77.17;NA;837;77.17;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11S;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IA;63;FEMALE;0;Alive;73.23;NA;650;1.35;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A11U;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IVB;74;FEMALE;0;Alive;16.72;NA;271;16.72;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11V;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;64;FEMALE;0;Alive;19.55;NA;232;19.55;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11W;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;61;FEMALE;0;Alive;19.48;NA;339;19.48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11X;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-L;1;;;;;;;Grade 3;;;;Stage IIIC2;66;FEMALE;0;Alive;19.58;NA;337;13.04;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-B5-A11Y;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSI-L;3;;;;;;;Grade 1;;;;Stage IB;59;FEMALE;0;Alive;18.4;NA;315;18.4;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A11Z;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;61;FEMALE;0;Alive;17.35;NA;291;17.35;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A121;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IIIA;57;FEMALE;0;Alive;16.56;NA;259;16.56;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A1MR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIA;65;FEMALE;0;Alive;225.33;NA;5691;225.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A1MV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-L;NA;;;;;;;Grade 2;;;;Stage IA;84;FEMALE;0;Alive;51.41;NA;380;51.41;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A1MW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 3;;;;Stage IA;55;FEMALE;0;Alive;14.68;NA;220;10.22;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A1MX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IB;47;FEMALE;0;Alive;48.39;NA;175;48.39;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A1MZ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-L;NA;;;;;;;Grade 1;;;;Stage IA;54;FEMALE;0;Alive;52.5;NA;465;20.14;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A3F9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;56;FEMALE;0;Alive;136.5;NA;3264;136.5;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A3FA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IC;73;FEMALE;0;Alive;96.22;NA;2565;96.22;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A3FB;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;73;FEMALE;0;Alive;93.43;NA;2096;93.43;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A3FC;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;53;FEMALE;0;Alive;71.78;NA;1890;71.78;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A3FH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;74;FEMALE;0;Alive;27.63;NA;197;27.63;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-B5-A3S1;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC1;71;FEMALE;0;Alive;29.63;NA;153;29.63;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-B5-A5OC;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIB;71;FEMALE;0;Alive;41.03;NA;841;41.03;DiseaseFree;;;NO;;NA;;
TCGA-B5-A5OD;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;67;FEMALE;0;Alive;34.1;NA;772;34.1;DiseaseFree;;;NO;;NA;;
TCGA-B5-A5OE;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC2;68;FEMALE;0;Alive;34.92;NA;734;34.92;DiseaseFree;;;NO;;NA;;
TCGA-BG-A0LW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IA;47;FEMALE;0;Alive;18.59;NA;195;18.59;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0LX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IB;57;FEMALE;0;Alive;20.17;NA;253;20.17;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0M0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IA;66;FEMALE;0;Alive;19.32;NA;238;19.32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0M2;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;62;FEMALE;0;Alive;20.93;NA;317;20.93;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0M3;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;74;FEMALE;0;Alive;35.18;NA;742;35.18;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0M4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IA;60;FEMALE;0;Alive;71.19;NA;480;71.19;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0M7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IIIC1;60;FEMALE;0;Alive;63.63;NA;698;63.63;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0M8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 3;;;;Stage IA;50;FEMALE;0;Alive;66.36;NA;690;66.36;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0M9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IB;73;FEMALE;0;Alive;74.57;NA;765;74.57;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0MC;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;74;FEMALE;0;Alive;41.49;NA;827;41.49;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0MG;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;1;;;;;;;Grade 1;;;;Stage IA;73;FEMALE;0;Alive;48.52;NA;896;48.52;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0MH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 2;;;;Stage IC;61;FEMALE;0;Alive;63.4;NA;1341;63.4;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0MO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;63;FEMALE;0;Alive;43;NA;1021;43;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0MQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 1;;;;Stage IA;71;FEMALE;0;Alive;59.69;NA;761;59.69;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-BG-A0MS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 3;;;;Stage IIIC1;53;FEMALE;0;Alive;61.83;NA;553;61.83;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0MT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IA;64;FEMALE;0;Alive;21.16;NA;240;18.56;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-BG-A0MU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IIIA;78;FEMALE;0;Alive;20.27;NA;232;20.27;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0RY;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IB;68;FEMALE;0;Alive;15.41;NA;128;15.41;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0VT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IIIA;56;FEMALE;0;Alive;51.51;NA;224;51.51;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0VV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;53;FEMALE;0;Alive;51.02;NA;272;51.02;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0VW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IA;77;FEMALE;0;Alive;51.97;NA;132;51.97;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0VX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IB;58;FEMALE;0;Alive;34.26;NA;490;34.26;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0VZ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IIIA;58;FEMALE;0;Alive;52.6;NA;868;52.6;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0W1;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage II;89;FEMALE;0;Alive;52.79;NA;908;52.79;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0W2;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;57;FEMALE;0;Alive;56.54;NA;1151;56.54;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0YU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;37;FEMALE;0;Alive;14.82;NA;279;14.82;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A0YV;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIA;67;FEMALE;0;Alive;12.55;NA;186;12.55;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A186;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IIIA;61;FEMALE;0;Alive;13.76;NA;230;13.76;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A187;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSI-L;3;;;;;;;Grade 2;;;;Stage IB;65;FEMALE;0;Alive;14.72;NA;231;14.72;DiseaseFree;;;NA;;NA;;
TCGA-BG-A18A;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;74;FEMALE;0;Alive;13.99;NA;252;13.99;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A18B;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage I;53;FEMALE;0;Alive;15.44;NA;155;15.44;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A18C;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 2;;;;Stage IA;72;FEMALE;0;Alive;15.44;NA;169;15.44;DiseaseFree;;;NA;;NA;;
TCGA-BG-A220;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;69;FEMALE;0;Alive;14.26;NA;221;14.26;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A221;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IB;84;FEMALE;0;Alive;1.81;NA;46;1.81;DiseaseFree;;;NA;;NA;;
TCGA-BG-A222;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;49;FEMALE;0;Alive;9.56;NA;14;9.56;DiseaseFree;;;NA;;NA;;
TCGA-BG-A2AD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIB;63;FEMALE;0;Alive;20.01;NA;609;20.01;DiseaseFree;;;NA;;NA;;
TCGA-BG-A2AE;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;1;;;;;;;Grade 3;;;;Stage IB;57;FEMALE;0;Alive;23.69;NA;327;23.69;DiseaseFree;;;NA;;NA;;
TCGA-BG-A2L7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;68;FEMALE;0;Alive;20.11;NA;177;20.11;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A3EW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage III;62;FEMALE;0;Alive;11.3;NA;5;11.3;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BG-A3PP;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;82;FEMALE;0;Alive;22.37;NA;207;21.85;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-BK-A0C9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IB;57;FEMALE;0;Alive;35.87;NA;289;35.87;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BK-A0CA;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;CN low;MSS;2;;;;;;;Grade 3;;;;Stage IIIC;61;FEMALE;0;Alive;34.95;NA;371;34.95;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BK-A0CB;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IIIC;60;FEMALE;0;Alive;35.87;NA;189;35.87;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BK-A0CC;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;69;FEMALE;0;Alive;35.05;NA;212;33.18;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-BK-A13B;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;58;FEMALE;0;Alive;31.73;NA;578;25.2;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-BK-A13C;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;47;FEMALE;0;Alive;24.97;NA;202;24.97;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BK-A26L;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC1;71;FEMALE;0;Alive;24.11;NA;234;24.11;DiseaseFree;;;NA;;NA;;
TCGA-BK-A4ZD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;42;FEMALE;0;Alive;16.62;NA;211;16.62;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-BK-A56F;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;75;FEMALE;0;Alive;13.17;NA;200;13.17;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-BK-A6W3;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;34;FEMALE;0;Alive;10.02;NA;86;10.02;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-BK-A6W4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;62;FEMALE;0;Alive;9.86;NA;158;9.86;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-BS-A0TC;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;3;;;;;;;Grade 1;;;;Stage IB;69;FEMALE;0;Alive;85.48;NA;2260;85.48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0TD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IB;65;FEMALE;0;Alive;78.15;NA;2003;78.15;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0TG;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IIIA;60;FEMALE;0;Alive;77.89;NA;2035;77.89;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0TI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 3;;;;Stage IC;64;FEMALE;0;Alive;61.83;NA;1443;61.83;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0TJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IC;59;FEMALE;0;Alive;67.94;NA;1514;67.94;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0U5;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;76;FEMALE;0;Alive;96.42;NA;2204;96.42;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0U8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 1;;;;Stage IIIC;55;FEMALE;0;Alive;97.34;NA;2606;97.34;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0U9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIA;59;FEMALE;0;Alive;92.81;NA;1749;92.81;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0UA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 1;;;;Stage IB;68;FEMALE;0;Alive;114.82;NA;2540;17.08;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-BS-A0UF;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;1;;;;;;;Grade 3;;;;Stage IB;65;FEMALE;0;Alive;85.78;NA;1843;85.78;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0UJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IA;68;FEMALE;0;Alive;82.33;NA;27;82.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0UL;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IA;54;FEMALE;0;Alive;81.5;NA;36;81.5;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0UM;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 1;;;;Stage IB;64;FEMALE;0;Alive;86.86;NA;2191;47.77;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-BS-A0UT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IIB;62;FEMALE;0;Alive;72.67;NA;595;72.67;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0UV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;55;FEMALE;0;Alive;73.19;NA;149;73.19;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0V4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 1;;;;Stage IB;56;FEMALE;0;Alive;59.46;NA;31;59.46;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0V6;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IB;55;FEMALE;0;Alive;89.52;NA;1650;89.52;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0V7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 1;;;;Stage IB;48;FEMALE;0;Alive;63.53;NA;1429;63.53;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0V8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 2;;;;Stage IIB;68;FEMALE;0;Alive;83.57;NA;1507;83.57;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0VI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;3;;;;;;;Grade 3;;;;Stage IIB;58;FEMALE;0;Alive;86.93;NA;1661;86.93;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-BS-A0WQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IA;55;FEMALE;0;Alive;66.43;NA;1208;66.43;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZN;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IA;60;FEMALE;0;Alive;16.82;NA;512;14.72;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 1;;;;Stage IB;75;FEMALE;0;Alive;19.78;NA;69;19.78;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZP;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSI-L;1;;;;;;;Grade 3;;;;Stage IVA;59;FEMALE;0;Alive;29.93;NA;690;20.66;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-D1-A0ZQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;90;FEMALE;0;Alive;8.54;NA;8;8.54;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;57;FEMALE;0;Alive;0.56;NA;17;0.56;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IB;54;FEMALE;0;Alive;4.86;NA;148;4.86;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;34;FEMALE;0;Alive;28.65;NA;578;28.65;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IB;58;FEMALE;0;Alive;23.92;NA;350;23.92;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A0ZZ;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;80;FEMALE;0;Alive;22.54;NA;377;22.54;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A101;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 2;;;;Stage IB;60;FEMALE;0;Alive;1.74;NA;53;1.74;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A102;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IB;49;FEMALE;0;Alive;4.43;NA;43;4.43;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A103;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSI-H;2;;;;;;;Grade 1;;;;Stage IB;87;FEMALE;0;Alive;21.98;NA;480;21.98;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A15V;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;68;FEMALE;0;Alive;39.45;NA;1012;39.45;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A15W;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IIIC;58;FEMALE;0;Alive;30.06;NA;915;30.06;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A15X;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN low;MSI-L;1;;;;;;;Grade 3;;;;Stage IA;45;FEMALE;0;Alive;29.86;NA;909;29.86;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A160;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IB;70;FEMALE;0;Alive;3.68;NA;112;3.68;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A161;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IC;78;FEMALE;0;Alive;29.3;NA;892;29.3;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A162;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 1;;;;Stage IB;69;FEMALE;0;Alive;37.61;NA;976;37.61;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A163;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IIIC;50;FEMALE;0;Alive;32.56;NA;938;7.33;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-D1-A165;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IIIA;64;FEMALE;0;Alive;0.66;NA;20;0.66;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A167;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 2;;;;Stage IC;70;FEMALE;0;Alive;15.7;NA;478;15.7;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A168;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 3;;;;Stage IB;67;FEMALE;0;Alive;36.07;NA;913;36.07;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A169;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 2;;;;Stage IV;63;FEMALE;0;Alive;37.29;NA;905;17.05;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-D1-A16B;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IC;64;FEMALE;0;Alive;36.33;NA;744;36.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16D;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IC;49;FEMALE;0;Alive;37.48;NA;908;37.48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16E;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IB;73;FEMALE;0;Alive;36.76;NA;909;36.76;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16F;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;3;;;;;;;Grade 2;;;;Stage IB;60;FEMALE;0;Alive;2.63;NA;80;2.63;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16J;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IIB;61;FEMALE;0;Alive;29.89;NA;742;29.89;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16N;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIA;51;FEMALE;0;Alive;31.04;NA;640;31.04;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16O;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 1;;;;Stage IB;44;FEMALE;0;Alive;33.61;NA;865;33.61;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16Q;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage II;54;FEMALE;0;Alive;10.64;NA;221;10.64;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16R;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 1;;;;Stage IA;39;FEMALE;0;Alive;0.69;NA;21;0.69;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16S;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;3;;;;;;;Grade 3;;;;Stage IIIC;70;FEMALE;0;Alive;18.66;NA;238;18.66;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16X;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSS;3;;;;;;;Grade 2;;;;Stage IB;54;FEMALE;0;Alive;3.65;NA;111;3.65;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A16Y;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSI-L;3;;;;;;;Grade 1;;;;Stage IB;56;FEMALE;0;Alive;17.48;NA;532;17.48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A174;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IA;51;FEMALE;0;Alive;19.51;NA;324;19.51;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A175;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IC;48;FEMALE;0;Alive;6.64;NA;202;6.64;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A176;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IB;67;FEMALE;0;Alive;30.12;NA;506;30.12;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A177;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IB;70;FEMALE;0;Alive;18;NA;347;11.4;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-D1-A17A;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IIA;59;FEMALE;0;Alive;1.58;NA;19;1.58;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17B;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 2;;;;Stage IB;69;FEMALE;0;Alive;7;NA;213;7;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17C;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;78;FEMALE;0;Alive;0.99;NA;1;0.99;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17D;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IB;58;FEMALE;0;Alive;30.42;NA;160;30.42;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17F;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 2;;;;Stage IA;68;FEMALE;0;Alive;1.28;NA;39;1.28;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17H;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 1;;;;Stage IB;61;FEMALE;0;Alive;27.99;NA;454;27.99;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17K;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 2;;;;Stage IA;74;FEMALE;0;Alive;28.06;NA;429;26.77;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-D1-A17L;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;81;FEMALE;0;Alive;26.35;NA;459;26.35;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17M;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 1;;;;Stage II;56;FEMALE;0;Alive;10.22;NA;311;10.22;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17N;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IA;46;FEMALE;0;Alive;1.51;NA;46;1.51;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17Q;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;POLE;MSI-L;3;;;;;;;Grade 2;;;;Stage IA;54;FEMALE;0;Alive;1.77;NA;54;1.77;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17S;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 1;;;;Stage IA;59;FEMALE;0;Alive;24.28;NA;326;24.28;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17T;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IA;67;FEMALE;0;Alive;2.33;NA;71;2.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A17U;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IIIC2;53;FEMALE;0;Alive;22.9;NA;396;22.9;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1NS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 1;;;;Stage IA;53;FEMALE;0;Alive;1.41;NA;43;1.41;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1NU;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IA;74;FEMALE;0;Alive;13.21;NA;312;13.21;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1NW;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IVB;72;FEMALE;0;Alive;0.72;NA;22;0.72;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1NX;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;66;FEMALE;0;Alive;18.23;NA;399;15.64;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-D1-A1NY;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IB;67;FEMALE;0;Alive;16.85;NA;396;16.85;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1NZ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 1;;;;Stage IA;60;FEMALE;0;Alive;18;NA;8;18;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1O0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IA;77;FEMALE;0;Alive;2.07;NA;2;2.07;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1O5;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 1;;;;Stage IA;61;FEMALE;0;Alive;15.05;NA;377;15.05;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A1O7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 1;;;;Stage IA;60;FEMALE;0;Alive;1.05;NA;32;1.05;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A2G0;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSI-H;NA;;;;;;;Grade 3;;;;Stage IB;70;FEMALE;0;Alive;48.75;NA;107;48.75;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A2G5;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 3;;;;Stage IB;50;FEMALE;0;Alive;47.8;NA;1260;36.86;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-D1-A3DA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC1;77;FEMALE;0;Alive;15.87;NA;8;15.87;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A3DH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;71;FEMALE;0;Alive;18.82;NA;125;18.82;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-D1-A3JP;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;61;FEMALE;0;Alive;16.92;NA;515;16.92;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-D1-A3JQ;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;61;FEMALE;0;Alive;17.28;NA;526;17.28;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-DF-A2KN;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IC;NA;FEMALE;0;Alive;2.2;NA;67;2.2;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-DF-A2KR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;84;FEMALE;0;Alive;71.55;NA;2178;69.42;Recurred/Progressed;;;NO;;TUMOR FREE;;
TCGA-DF-A2KS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;69;FEMALE;0;Alive;109;NA;2188;74.8;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-DF-A2KU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;NA;FEMALE;0;Alive;100.76;NA;1983;100.76;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-DF-A2KV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;55;FEMALE;0;Alive;89.26;NA;936;89.26;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-DF-A2KY;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVA;49;FEMALE;0;Alive;10.91;NA;332;10.91;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-DF-A2KZ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;87;FEMALE;0;Alive;27.14;NA;826;27.14;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-DI-A0WH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IB;64;FEMALE;0;Alive;16.29;NA;405;16.29;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-DI-A1BU;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSI-H;NA;;;;;;;Grade 3;;;;Stage IIB;55;FEMALE;0;Alive;39.26;NA;1005;39.26;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-DI-A1BY;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 2;;;;Stage IIB;63;FEMALE;0;Alive;36.6;NA;1114;36.6;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-DI-A1C3;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage IB;38;FEMALE;0;Alive;24.28;NA;739;24.28;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-DI-A1NN;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;63;FEMALE;0;Alive;35.35;NA;944;33.61;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-E6-A1LX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage IB;40;FEMALE;0;Alive;23.36;NA;711;23.36;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-E6-A1LZ;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IA;76;FEMALE;0;Alive;79.04;NA;1289;79.04;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-E6-A1M0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;56;FEMALE;0;Alive;58.9;NA;428;58.9;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-E6-A2P9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;65;FEMALE;0;Alive;45.53;NA;203;45.53;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-E6-A8L9;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;61;FEMALE;0;Alive;33.28;NA;740;33.28;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-EC-A1NJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 2;;;;Stage IA;73;FEMALE;0;Alive;16.03;NA;0;16.03;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EC-A1QX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IB;71;FEMALE;0;Alive;7.36;NA;66;7.19;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-EC-A24G;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage II;57;FEMALE;0;Alive;16.79;NA;47;16.79;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A1Y5;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;63;FEMALE;0;Alive;10.91;NA;332;10.91;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A1Y7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 3;;;;Stage IB;65;FEMALE;0;Alive;49.11;NA;243;28.91;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-EO-A1Y8;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IA;87;FEMALE;0;Alive;37.68;NA;328;37.68;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A22R;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;56;FEMALE;0;Alive;61.7;NA;972;61.7;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A22S;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;58;FEMALE;0;Alive;61.5;NA;1066;61.5;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A22T;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;56;FEMALE;0;Alive;66.85;NA;1004;66.85;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A22U;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;83;FEMALE;0;Alive;46.22;NA;825;46.22;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A22X;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;36;FEMALE;0;Alive;57.56;NA;982;57.56;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A22Y;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;68;FEMALE;0;Alive;51.48;NA;754;51.48;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A2CG;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;69;FEMALE;0;Alive;51.38;NA;752;51.38;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3AS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;86;FEMALE;0;Alive;34.36;NA;1046;34.36;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3AU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;72;FEMALE;0;Alive;50.69;NA;589;38.7;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-EO-A3AV;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC1;51;FEMALE;0;Alive;35.12;NA;573;35.12;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3AY;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;58;FEMALE;0;Alive;38.04;NA;392;38.21;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-EO-A3AZ;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage IB;80;FEMALE;0;Alive;27.14;NA;469;27.14;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3B0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC2;43;FEMALE;0;Alive;46.39;NA;404;46.39;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3B1;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;63;FEMALE;0;Alive;26.94;NA;337;26.94;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3KU;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;68;FEMALE;0;Alive;22.24;NA;254;22.24;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3KW;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;72;FEMALE;0;Alive;16.33;NA;182;16.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3KX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;80;FEMALE;0;Alive;38.44;NA;281;38.44;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EO-A3L0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;76;FEMALE;0;Alive;51.05;NA;577;51.05;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GC;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IB;62;FEMALE;0;Alive;54.11;NA;138;54.11;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 1;;;;Stage IA;51;FEMALE;0;Alive;53.84;NA;248;53.84;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GE;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 1;;;;Stage IA;67;FEMALE;0;Alive;24.34;NA;552;24.34;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GF;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 2;;;;Stage IA;75;FEMALE;0;Alive;27.14;NA;532;27.14;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GH;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage IA;70;FEMALE;0;Alive;23.32;NA;528;23.32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage IB;52;FEMALE;0;Alive;23.32;NA;507;23.32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 3;;;;Stage IA;73;FEMALE;0;Alive;23.88;NA;511;23.88;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IB;74;FEMALE;0;Alive;22.77;NA;504;22.77;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GL;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage II;51;FEMALE;0;Alive;33.31;NA;425;33.31;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 2;;;;Stage IIIC1;65;FEMALE;0;Alive;19.25;NA;360;16.98;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-EY-A1GP;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 1;;;;Stage IA;54;FEMALE;0;Alive;18.82;NA;348;18.82;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IB;76;FEMALE;0;Alive;17.87;NA;340;10.97;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-EY-A1GR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IA;67;FEMALE;0;Alive;17.61;NA;344;17.61;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 1;;;;Stage IIIA;68;FEMALE;0;Alive;16.1;NA;300;16.1;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1GV;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSS;3;;;;;;;Grade 3;;;;Stage IIIC1;75;FEMALE;0;Alive;15.8;NA;257;15.8;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A1H0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 2;;;;Stage IIIC2;57;FEMALE;0;Alive;19.32;NA;339;19.32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A210;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSI-L;NA;;;;;;;Grade 3;;;;Stage IIIC2;82;FEMALE;0;Alive;12.58;NA;166;12.58;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A214;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 3;;;;Stage IIIC1;66;FEMALE;0;Alive;14.39;NA;252;14.39;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A215;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 3;;;;Stage IB;60;FEMALE;0;Alive;18.86;NA;391;18.86;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A2OM;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;55;FEMALE;0;Alive;22.8;NA;236;22.8;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A2OO;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage IB;56;FEMALE;0;Alive;45.73;NA;774;45.73;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A2OP;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;63;FEMALE;0;Alive;31.01;NA;504;31.01;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A2OQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;61;FEMALE;0;Alive;29.07;NA;294;29.07;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A3L3;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;82;FEMALE;0;Alive;27.33;NA;258;27.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-EY-A547;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;75;FEMALE;0;Alive;17.9;NA;545;17.9;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-EY-A548;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;83;FEMALE;0;Alive;14.13;NA;65;14.13;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-EY-A549;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;78;FEMALE;0;Alive;19.88;NA;212;19.88;DiseaseFree;;;[Unknown];;TUMOR FREE;;
TCGA-EY-A54A;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC2;67;FEMALE;0;Alive;14.68;NA;113;14.68;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-EY-A5W2;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;72;FEMALE;0;Alive;16.95;NA;161;16.95;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-EY-A72D;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;87;FEMALE;0;Alive;5.88;NA;179;5.88;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-FI-A2CX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IB;82;FEMALE;0;Alive;66.72;NA;1217;66.72;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-FI-A2CY;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IA;60;FEMALE;0;Alive;68.33;NA;1064;68.33;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-FI-A2D0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IA;55;FEMALE;0;Alive;39.85;NA;1034;39.85;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-FI-A2EU;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IA;68;FEMALE;0;Alive;96.62;NA;2557;96.62;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-FI-A2EW;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;Indeterminant;1;;;;;;;Grade 3;;;;Stage IIB;71;FEMALE;0;Alive;58.97;NA;1795;38.4;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-FI-A2EX;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIA;58;FEMALE;0;Alive;9.33;NA;276;7;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-FI-A2F4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 3;;;;Stage IC;64;FEMALE;0;Alive;73.26;NA;881;73.26;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-FI-A2F8;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage II;64;FEMALE;0;Alive;30.65;NA;761;30.65;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-FI-A2F9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IA;79;FEMALE;0;Alive;59.23;NA;791;59.23;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-FI-A3PX;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC2;57;FEMALE;0;Alive;78.32;NA;1369;78.32;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-H5-A2HR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;71;FEMALE;0;Alive;1.74;NA;53;1.74;DiseaseFree;;;NA;;TUMOR FREE;;
TCGA-KJ-A3U4;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;55;FEMALE;0;Alive;35.97;NA;74;10.05;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-KP-A3VZ;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IV;69;FEMALE;0;Alive;23.72;NA;722;23.72;DiseaseFree;;;NA;;WITH TUMOR;;
TCGA-KP-A3W0;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;72;FEMALE;0;Alive;13.27;NA;404;13.27;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-KP-A3W1;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;76;FEMALE;0;Alive;9.46;NA;288;9.46;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-KP-A3W3;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;72;FEMALE;0;Alive;26.08;NA;794;21.71;Recurred/Progressed;;;YES;;WITH TUMOR;;
TCGA-PG-A5BC;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;72;FEMALE;0;Alive;23.23;NA;329;23.23;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-PG-A6IB;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;68;FEMALE;0;Alive;21.29;NA;277;21.29;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-PG-A7D5;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;62;FEMALE;0;Alive;38.67;NA;729;38.67;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-PG-A914;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;73;FEMALE;0;Alive;22.57;NA;393;22.57;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-PG-A915;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;60;FEMALE;0;Alive;8.18;NA;213;8.18;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-PG-A916;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage I;70;FEMALE;0;Alive;17.15;NA;342;17.15;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-PG-A917;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;74;FEMALE;0;Alive;6.96;NA;212;6.96;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-QF-A5YS;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage II;57;FEMALE;0;Alive;22.63;NA;275;22.63;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-QF-A5YT;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;57;FEMALE;0;Alive;39.91;NA;887;39.91;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-QS-A5YQ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;55;FEMALE;0;Alive;24.93;NA;128;24.93;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-QS-A5YR;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIB;61;FEMALE;0;Alive;23.62;NA;168;23.62;DiseaseFree;;;NO;;WITH TUMOR;;
TCGA-QS-A744;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIB;86;FEMALE;0;Alive;14.82;NA;143;14.82;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-SJ-A6ZI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;64;FEMALE;0;Alive;20.73;NA;128;20.73;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-SJ-A6ZJ;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;61;FEMALE;0;Alive;18.27;NA;234;18.27;DiseaseFree;;;NO;;TUMOR FREE;;
TCGA-SL-A6J9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;73;FEMALE;0;Alive;0.07;NA;2;0.07;DiseaseFree;;;[Unknown];;[Unknown];;
TCGA-SL-A6JA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;77;FEMALE;0;Alive;0.23;NA;7;0.23;DiseaseFree;;;[Unknown];;TUMOR FREE;;
TCGA-A5-A0G1;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSI-H;3;;;;;;;Grade 3;;;;Stage IA;67;FEMALE;1;Dead;106.8;3251;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-A5-A0GA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIC2;67;FEMALE;1;Dead;17.84;543;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-A5-A0GD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 2;;;;Stage IA;75;FEMALE;1;Dead;112.45;NA;98;NA;NA;;;NA;;TUMOR FREE;;
TCGA-A5-A0VO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage IB;64;FEMALE;1;Dead;28.75;NA;128;NA;NA;;;NA;;TUMOR FREE;;
TCGA-A5-A1OG;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;65;FEMALE;1;Dead;31.96;NA;348;11.07;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-A5-A2K4;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;69;FEMALE;1;Dead;28.61;871;NA;17.35;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AJ-A23M;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage II;61;FEMALE;1;Dead;20.24;NA;36;16.95;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AJ-A23N;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;70;FEMALE;1;Dead;14.42;NA;33;NA;NA;;;NO;;WITH TUMOR;;
TCGA-AJ-A23O;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;3;;;;;;;Grade 3;;;;Stage IB;69;FEMALE;1;Dead;10.25;NA;60;NA;NA;;;NA;;TUMOR FREE;;
TCGA-AJ-A2QO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;85;FEMALE;1;Dead;34.33;NA;92;NA;NA;;;NA;;TUMOR FREE;;
TCGA-AJ-A3EJ;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage IIIC2;74;FEMALE;1;Dead;1.64;50;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-AJ-A3I9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage II;52;FEMALE;1;Dead;17.05;NA;39;12.16;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AJ-A3NH;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;90;FEMALE;1;Dead;10.18;NA;23;NA;NA;;;NA;;TUMOR FREE;;
TCGA-AJ-A3OL;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;55;FEMALE;1;Dead;14.75;NA;57;13.93;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-AP-A052;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IVB;59;FEMALE;1;Dead;21.98;669;NA;12.94;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A053;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IA;90;FEMALE;1;Dead;110.55;NA;18;NA;NA;;;NA;;TUMOR FREE;;
TCGA-AP-A054;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIC1;64;FEMALE;1;Dead;23.29;709;NA;18.59;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A05A;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage II;81;FEMALE;1;Dead;63.86;NA;1199;NA;NA;;;NA;;TUMOR FREE;;
TCGA-AP-A05N;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 1;;;;Stage IA;58;FEMALE;1;Dead;23.85;NA;239;NA;NA;;;NA;;TUMOR FREE;;
TCGA-AP-A0L8;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;70;FEMALE;1;Dead;48.75;1484;NA;47.73;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A0LH;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;CN high;MSS;2;;;;;;;Grade 3;;;;Stage IA;60;FEMALE;1;Dead;36.33;1106;NA;9.92;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A0LO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IA;45;FEMALE;1;Dead;33.38;1016;NA;16.95;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A1DP;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 2;;;;Stage IA;70;FEMALE;1;Dead;35.51;1081;NA;27.3;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A1DQ;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC1;76;FEMALE;1;Dead;46.75;NA;1185;29.73;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A3K1;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;56;FEMALE;1;Dead;21.88;NA;555;6.5;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AP-A5FX;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage IIIC1;68;FEMALE;1;Dead;36.1;NA;1026;13.37;Recurred/Progressed;;;YES;;WITH TUMOR;;
TCGA-AX-A05S;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IIIC;81;FEMALE;1;Dead;13.57;413;NA;11.1;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AX-A06D;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 2;;;;Stage IIIA;82;FEMALE;1;Dead;12.25;373;NA;8.31;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AX-A0IS;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;2;;;;;;;Grade 2;;;;Stage IC;52;FEMALE;1;Dead;61.04;NA;1065;14.72;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AX-A2H2;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIA;86;FEMALE;1;Dead;4.76;145;NA;NA;NA;;;NA;;NA;;
TCGA-AX-A2H4;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;66;FEMALE;1;Dead;30.09;916;NA;17.08;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AX-A2H7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IC;87;FEMALE;1;Dead;40.77;NA;1020;22.47;Recurred/Progressed;;;NA;;NA;;
TCGA-AX-A2HK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;77;FEMALE;1;Dead;2.96;90;NA;NA;NA;;;NA;;NA;;
TCGA-AX-A2IN;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IC;63;FEMALE;1;Dead;31.11;947;NA;11.76;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-AX-A3FX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIB;69;FEMALE;1;Dead;43.79;NA;4;40.47;Recurred/Progressed;;;NA;;NA;;
TCGA-AX-A3G1;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IC;84;FEMALE;1;Dead;20.5;624;NA;NA;NA;;;NA;;NA;;
TCGA-B5-A0K3;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IA;62;FEMALE;1;Dead;27.27;NA;700;17.38;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-B5-A0K9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;NA;;;;;;;Grade 1;;;;Stage II;88;FEMALE;1;Dead;13.44;NA;167;NA;NA;;;NA;;TUMOR FREE;;
TCGA-B5-A11L;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;3;;;;;;;Grade 2;;;;Stage IC;71;FEMALE;1;Dead;73.59;NA;1396;4.3;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A1MS;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IC;60;FEMALE;1;Dead;102.23;3112;NA;88.9;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-B5-A1MU;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IVB;79;FEMALE;1;Dead;50.85;1548;NA;44.84;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-B5-A1MY;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;62;FEMALE;1;Dead;11.86;361;NA;10.94;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-B5-A1N2;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC1;70;FEMALE;1;Dead;31.34;NA;389;26.41;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-B5-A3FD;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;70;FEMALE;1;Dead;39.32;NA;796;32.59;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-BG-A0M6;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC2;73;FEMALE;1;Dead;22.04;NA;241;NA;NA;;;NA;;TUMOR FREE;;
TCGA-BG-A0MA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage IB;60;FEMALE;1;Dead;10.71;326;NA;2.3;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-BG-A0MI;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 2;;;;Stage IA;83;FEMALE;1;Dead;23.46;714;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-BG-A0MK;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIB;52;FEMALE;1;Dead;43.27;1317;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-BK-A139;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;74;FEMALE;1;Dead;30.98;NA;239;22.47;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-BK-A139;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;74;FEMALE;1;Dead;30.98;NA;239;22.47;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-BS-A0T9;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSS;3;;;;;;;Grade 3;;;;Stage IVB;39;FEMALE;1;Dead;46.91;1428;NA;20.83;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-BS-A0TA;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 3;;;;Stage IVB;58;FEMALE;1;Dead;24.31;NA;714;19.09;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-BS-A0TE;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;1;;;;;;;Grade 3;;;;Stage IVB;35;FEMALE;1;Dead;4.8;146;NA;1.91;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-BS-A0U7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;2;;;;;;;Grade 2;;;;Stage IC;63;FEMALE;1;Dead;30.72;935;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-D1-A15Z;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;CN low;MSI-L;2;;;;;;;Grade 2;;;;Stage IB;72;FEMALE;1;Dead;1.91;58;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-D1-A16G;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IV;74;FEMALE;1;Dead;27.4;834;NA;21.09;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-D1-A16I;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IC;62;FEMALE;1;Dead;11.5;350;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-D1-A16V;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage IIIC;78;FEMALE;1;Dead;3.94;NA;43;NA;NA;;;NA;;TUMOR FREE;;
TCGA-D1-A179;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;76;FEMALE;1;Dead;14.72;NA;206;14.03;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-D1-A17R;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;MSI;MSI-H;3;;;;;;;Grade 2;;;;Stage IA;58;FEMALE;1;Dead;11.14;339;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-D1-A1O8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIC;70;FEMALE;1;Dead;3.94;120;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-D1-A2G6;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;3;;;;;;;Grade 3;;;;Stage IIIC;53;FEMALE;1;Dead;8.48;258;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-D1-A2G7;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IB;65;FEMALE;1;Dead;58.9;NA;1365;NA;NA;;;NA;;TUMOR FREE;;
TCGA-D1-A3DG;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;81;FEMALE;1;Dead;4.27;NA;130;NA;NA;;;NA;;TUMOR FREE;;
TCGA-DF-A2L0;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;60;FEMALE;1;Dead;25.89;788;NA;17.18;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-DI-A1NO;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIA;68;FEMALE;1;Dead;9.36;285;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-DI-A2QT;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC;51;FEMALE;1;Dead;12.39;377;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-DI-A2QU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;67;FEMALE;1;Dead;31.08;946;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-DI-A2QY;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIB;64;FEMALE;1;Dead;110.02;NA;2797;NA;NA;;;NA;;TUMOR FREE;;
TCGA-E6-A2P8;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;NA;NA;NA;;;;;;;NA;;;;Stage IV;53;FEMALE;1;Dead;2.37;72;NA;1.97;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-EO-A2CH;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;73;FEMALE;1;Dead;19.38;590;NA;18.89;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-EY-A1G7;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 2;;;;Stage II;86;FEMALE;1;Dead;6.21;189;NA;3.12;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-EY-A1G8;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IB;83;FEMALE;1;Dead;14.98;456;NA;NA;NA;;;NA;;TUMOR FREE;;
TCGA-EY-A1GM;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IIIA;60;FEMALE;1;Dead;32.69;NA;210;25.99;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-EY-A1GS;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IVB;71;FEMALE;1;Dead;22.01;NA;284;NA;NA;;;NA;;WITH TUMOR;;
TCGA-EY-A1GU;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;2;;;;;;;Grade 2;;;;Stage IB;66;FEMALE;1;Dead;32.75;NA;259;NA;NA;;;NA;;TUMOR FREE;;
TCGA-EY-A1GW;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;2;;;;;;;Grade 3;;;;Stage IVB;73;FEMALE;1;Dead;11.07;NA;260;6.24;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-EY-A1GX;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;NA;;;;;;;Grade 2;;;;Stage IIIA;76;FEMALE;1;Dead;37.02;NA;166;24.41;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-EY-A212;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IIIC1;83;FEMALE;1;Dead;10.18;NA;110;NA;NA;;;NA;;TUMOR FREE;;
TCGA-EY-A2ON;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;61;FEMALE;1;Dead;20.04;NA;171;7.42;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-EY-A3QX;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;64;FEMALE;1;Dead;32.49;NA;162;29.43;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-EY-A4KR;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC1;56;FEMALE;1;Dead;11.37;NA;196;NA;NA;;;[Unknown];;WITH TUMOR;;
TCGA-FI-A2D2;Uterine Corpus Endometroid Cancer;Mixed serous and endometrioid;CN high;MSS;1;;;;;;;Grade 3;;;;Stage IB;66;FEMALE;1;Dead;77.27;NA;1095;62.98;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-FI-A2D4;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IIIC;44;FEMALE;1;Dead;7.98;243;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-FI-A2D5;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSS;1;;;;;;;Grade 3;;;;Stage IVB;56;FEMALE;1;Dead;13.83;421;NA;9.2;Recurred/Progressed;;;NA;;WITH TUMOR;;
TCGA-FI-A2D6;Uterine Corpus Endometroid Cancer;Endometrioid endometrial adenocarcinoma;Notassigned;MSI-H;1;;;;;;;Grade 3;;;;Stage IB;74;FEMALE;1;Dead;25.2;NA;273;NA;NA;;;NA;;TUMOR FREE;;
TCGA-FI-A2EY;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;63;FEMALE;1;Dead;28.91;880;NA;18.96;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-FI-A3PV;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IA;68;FEMALE;1;Dead;41.52;1249;NA;NA;NA;;;NA;;WITH TUMOR;;
TCGA-JU-AAVI;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIC1;61;FEMALE;1;Dead;17.74;NA;236;16.59;Recurred/Progressed;;;NO;;TUMOR FREE;;
TCGA-K6-A3WQ;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IVB;60;FEMALE;1;Dead;14.03;NA;204;12.55;Recurred/Progressed;;;NA;;TUMOR FREE;;
TCGA-KP-A3W4;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;63;FEMALE;1;Dead;18.2;554;NA;10.55;Recurred/Progressed;;;YES;;WITH TUMOR;;
TCGA-QS-A8F1;Uterine Corpus Endometroid Cancer;Serous endometrial adenocarcinoma;NA;NA;NA;;;;;;;NA;;;;Stage IIIA;85;FEMALE;1;Dead;4.43;NA;125;NA;NA;;;NO;;WITH TUMOR;;
TCGA-2E-A9G8;Uterine Corpus Endometroid Cancer;NA;NA;NA;NA;;;;;;;NA;;;;NA;NA;NA;NA;NA;NA;NA;NA;NA;NA;;;NA;;NA;;
